CoChat

A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

OBJECTIVE—Zinc transporter eight (SLC30A8) is a major target of autoimmunity in human type 1A diabetes and is implicated in type 2 diabetes in genome-wide association studies. The type 2 diabetes nonsynonymous single nucleotide polymorphism (SNP) affecting aa325 lies within the region of highest ZnT8 autoantibody (ZnT8A) binding, prompting an investigation of its relationship to type 1 diabetes. RESEARCH DESIGN AND METHODS—ZnT8A radioimmunoprecipitation assays were performed in 421 new-onset type 1 diabetic Caucasians using COOH-terminal constructs incorporating the known human aa325 variants (Trp, Arg, and Gln). Genotypes were determined by PCR-based SNP analysis. RESULTS—Sera from 224 subjects (53%) were reactive to Arg325 probes, from 185 (44%) to Trp325probes, and from 142 (34%) to Gln325probes. Sixty subjects reacted only with Arg325 constructs, 31 with Trp325 only, and 1 with Gln325 only. The restriction to either Arg325 or Trp325 corresponded with inheritance of the respective C- or T-alleles. A strong gene dosage effect was also evident because both Arg- and Trp-restricted ZnT8As were less prevalent in heterozygous than homozygous individuals. The SLC30A8 SNP allele frequency (75% C and 25% T) varied little with age of type 1 diabetes onset or the presence of other autoantibodies. CONCLUSIONS—The finding that diabetes autoimmunity can be defined by a single polymorphic residue has not previously been documented. It argues against ZnT8 autoimmunity arising from molecular mimicry and suggests a mechanistic link between the two major forms of diabetes. It has implications for antigen-based therapeutic interventions because the response to ZnT8 administration could be protective or immunogenic depending on an individual's genotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db08-0522

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Relationship between autoantibody responses to Arg325, Trp325, and Gln325 constructs. A: Venn diagram illustrating the overlap of antibody detection with each of the polymorphic probes in the entire population (n = 421) in the study. The prevalence in each sector is expressed as a percentage of the population total. B–D: Assays were performed on the same set of 117 new-onset type 1 diabetic individuals and stratified as indicated; the numbers in each sector are shown in parentheses. The cutoff for positive responses was set at 0.05 (vertical and horizontal lines). Responses judged to be equivalent are set by the boundaries indicated by the angled lines, which correspond to a 3-SD excursion from the diagonal, assuming an intrassay coefficient of variation of 12.5% for each sample. Data are expressed as the immunoprecipitation index (sample-control)/(positive sample [BUNE]-control).
FIG. 1. Relationship between autoantibody responses to Arg325, Trp325, and Gln325 constructs. A: Venn diagram illustrating the overlap of antibody detection with each of the polymorphic probes in the entire population (n = 421) in the study. The prevalence in each sector is expressed as a percentage of the population total. B–D: Assays were performed on the same set of 117 new-onset type 1 diabetic individuals and stratified as indicated; the numbers in each sector are shown in parentheses. The cutoff for positive responses was set at 0.05 (vertical and horizontal lines). Responses judged to be equivalent are set by the boundaries indicated by the angled lines, which correspond to a 3-SD excursion from the diagonal, assuming an intrassay coefficient of variation of 12.5% for each sample. Data are expressed as the immunoprecipitation index (sample-control)/(positive sample [BUNE]-control).CC BY-NC-ND · PubMed Central
FIG. 2. Preabsorption of autoantibodies with recombinant proteins. Single sera samples were selected from hCArg-restricted sera, hCTrp-restricted sera, or samples that react equivalently with hCGln, hCArg, and hCTrp probes. Samples were preincubated without (-) or with 10 μg of the indicated affinity-purified NUS-C-term ZnT8 fusion protein for 2 h at room temperature before addition of the designated labeled probe and then processed by the usual procedure.
FIG. 2. Preabsorption of autoantibodies with recombinant proteins. Single sera samples were selected from hCArg-restricted sera, hCTrp-restricted sera, or samples that react equivalently with hCGln, hCArg, and hCTrp probes. Samples were preincubated without (-) or with 10 μg of the indicated affinity-purified NUS-C-term ZnT8 fusion protein for 2 h at room temperature before addition of the designated labeled probe and then processed by the usual procedure.CC BY-NC-ND · PubMed Central
FIG. 3. Prevalence of genotypes, autoantibodies to ZnT8, and other antigens in relation to age ofclinical diagnosis. Data from 335 individuals were subdivided in groups 4 years apart and analyzed with respect to distribution of genotypes (A); presence of insulin, GAD, and IA-2 autoantibodies (B); ZnT8 autoreactivity as defined by Gln, Arg, and Trp probes (C); and ZnT8 autoreactivity relative to isoepitope classification (D). Statistical significance relative to the 5- to 15-year-old reference group was determined by Fisher's exact test: *P < 0.05; **P < 0.01. IAA, insulin autoantibody.
FIG. 3. Prevalence of genotypes, autoantibodies to ZnT8, and other antigens in relation to age ofclinical diagnosis. Data from 335 individuals were subdivided in groups 4 years apart and analyzed with respect to distribution of genotypes (A); presence of insulin, GAD, and IA-2 autoantibodies (B); ZnT8 autoreactivity as defined by Gln, Arg, and Trp probes (C); and ZnT8 autoreactivity relative to isoepitope classification (D). Statistical significance relative to the 5- to 15-year-old reference group was determined by Fisher's exact test: *P < 0.05; **P < 0.01. IAA, insulin autoantibody.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

Metadata

Authors
Wenzlau, J. M., Liu, Y., Yu, L., Moua, O., Fowler, K. T., Rangasamy, S., Walters, J., Eisenbarth, G. S., Davidson, H. W., & Hutton, J. C.
Affiliations
  • University of Colorado Denver (US)
  • Jiangsu Province Hospital (CN)
Venue
Diabetes
Published
2008-10-01
Volume
57
Issue
10
Pages
2693-2697
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2134857194
Cited by
205
References
24
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 9 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 10 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 12 · 2012: 23
FWCI
10.09
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association (P30 DK57516)
  • National Institutes of Health (NIH-R01, NIH R01 DK052068, DK052068, DK57516)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, P30 DK 57516, R01DK052068)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
SLC30A8, zinc transporter 8, ZnT8 autoantibodies, type 1 diabetes, type 2 diabetes, non-synonymous single nucleotide polymorphisms, autoantibody specificity, gene dosage effect, molecular mimicry, autoimmunity
MeSH terms
Zinc Transporter 8, Adolescent, Adult, Antibody Specificity, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Genotype, Humans, Infant, Middle Aged, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Cation Transport Proteins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.